Atalanta Therapeutics Appoints Serena Hung as Chief Medical Officer and Jeffrey Young as Chief Financial Officer
Position
Chief Medical Officer
Company
Atalanta Therapeutics
BostonBiotechnologyHealth CareTherapeuticsDescription
Atalanta Therapeutics announced the appointments of Serena Hung, M.D., as chief medical officer, and Jeffrey Young as chief financial officer. Dr. Hung is a board-certified neurologist with leadership roles at prominent CNS drug development companies, while Mr
Quick answer
Atalanta Therapeutics Appoints Serena Hung as Chief Medical Officer and Jeffrey Young as Chief Financial Officer (May 22, 2024). Atalanta Therapeutics is based in Boston, Massachusetts, United States.
- Who is the new Chief Medical Officer at Atalanta Therapeutics?
- Atalanta Therapeutics named Serena Hung Chief Medical Officer, announced May 22, 2024.
- What did Atalanta Therapeutics announce on May 22, 2024?
- Atalanta Therapeutics announced the appointments of Serena Hung, M.D., as chief medical officer, and Jeffrey Young as chief financial officer.
- What does Atalanta Therapeutics do?
- Atalanta Therapeutics is a biotechnology company pioneering RNA interference (RNAi) for the treatment of neurological diseases.
- Where is Atalanta Therapeutics based?
- Atalanta Therapeutics is based in Boston, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Oragenics (May 22, 2024), Kronos Bio (May 21, 2024), Veristat (May 23, 2024) and Chroma Medicine (May 20, 2024) also announced leadership changes within 45 days of Atalanta Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Oragenics Appoints Dr. William “Frank” Peacock as Chief Clinical Officer for Conducting Phase II Clinical Trial (May 22, 2024)
- Kronos Bio Appoints Deborah Knobelman, Ph.D., as Chief Operating Officer and Chief Financial Officer (May 21, 2024)
- Veristat Appoints Rachel Page as Chief Commercial Officer and Cindy Henderson as Chief Strategy Officer (May 23, 2024)
- Chroma Medicine Appoints Jenny Marlowe, Ph.D., as Chief Development Officer (May 20, 2024)
- CRISPR Therapeutics Appoints Naimish Patel as Chief Medical Officer and Julianne Bruno as Chief Operating Officer (May 24, 2024)
- HaemaLogiX Appoints Professor the Hon Greg Hunt as Non-Executive Director (May 20, 2024)
Who to call at Atalanta Therapeutics, and when
A new leader at Atalanta Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Atalanta Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atalanta Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atalanta Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atalanta Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Atalanta Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.